《大行報告》花旗升滔搏(06110.HK)目標價至16.26元 評級「買入」
花旗發表報告表示,Nike及Adidas今年1至2月份在中國銷售及息稅前利潤率高於預期下,料滔搏(06110.HK)2021年下半年度(去年10月至今年2月)純利按年升60%,而全年度計純利料升15%,較市場平均預測高9%。
報告又指,預計隨著Adidas五年戰略計劃的實施,Adidas將在今明兩年縮窄與Nike在中國的增長差距,對滔搏有結構性正面影響,該行將滔搏2021至2022財年盈利預測上調6%及5%,目標價由14.55元升至16.26元,維持「買入」評級。
花旗料李寧(02331.HK)年度業績和Nike第三季業績(3月19日出爐)將成為滔搏下一個正面催化劑。在中國體育行業中,花旗推薦滔搏和李寧。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.